Abstract:Cardiovascular disease is the leading cause of death in the world. The phospholipase C (PLC) family of enzymes, in particular the PLCε subfamily, are essential for normal cardiovascular function. PLCε hydrolyzes phosphatidylinositol phosphates at cellular membranes, producing inositol phosphates (IPx) and diacylglycerol (DAG). These crucial secondary messengers activate multiple downstream pathways, including cardiac contractility and the expression of hypertrophic genes. In the cardiovascular system, PLCε is regulated through direct interactions with the RhoA and Rap1A small GTPases, which in turn are activated downstream of G protein‐coupled receptors (GPCRs). RhoA is reported to activate PLCε at the plasma membrane, whereas Rap1A translocates and activates PLCε at the perinuclear membrane. However, the elements within PLCε that regulate basal activity and membrane association have not been fully identified. Similarly, the domains involved in Rap1A versus RhoA binding, activation and translocation to different subcellular membranes have not been mapped. In this work, we use a structure‐guided approach, together with cell‐based activity assays, epifluorescence, and confocal microscopy to identify the roles of PLCε regulatory elements and domains in basal activity, subcellular localization, and regulation by RhoA and Rap1A GTPases. Functional studies show N‐ and C‐terminal regulatory domains of PLCε dictate its location within the cell, and contribute differently to basal and G protein‐dependent activity. We also show that regulatory insertions within the catalytic TIM barrel, including the X–Y linker and Y‐box, aid in interfacial activation and membrane association. These studies provide much needed insights into the molecular determinants of PLCε that regulate its localization and activity in cells, which is critical for elucidating its roles in cardiovascular function.

PhospholipaseCγ1/calcium-dependent membranous localization of Gsdmd-N drives endothelial pyroptosis, contributing to lipopolysaccharide-induced fatal outcome

O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyroptosis

Inverse regulation of GSDMD and GSDME gene expression during LPS-induced pyroptosis in RAW264.7 macrophage cells

Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis

Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis

Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Gasdermin D in pyroptosis

Understanding the Molecular Mechanism of PLCε Regulation and G Protein‐Mediated Activation

GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Pore formation by GSDMD is the effector mechanism of pyroptosis

Gasdermin D:The killer protein performs cell pyroptosis

Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

New insights into Gasdermin D pore formation

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis

Pore-forming activity and structural autoinhibition of the gasdermin family

Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture

GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis